A collection of devices designed to conduct fluids from an intravenous (IV) fluid container to a patient's venous system via a previously implanted injection/infusion port. It typically includes a noncoring needle designed with a lateral hole (side-hole), tubi
| Company | Devices | Share |
|---|---|---|
| Bard Access Systems, Inc. | 603 | 59% |
| Vygon Corporation | 117 | 11% |
| Sb-Kawasumi Laboratories, Inc. | 74 | 7% |
| All-Med Inc | 49 | 5% |
| Jiangsu Caina Medical Co.,Ltd | 42 | 4% |
| B. Braun Medical Inc. | 24 | 2% |
| Infusion Safety Products, Inc. | 24 | 2% |
| Progressive Medical, Inc. | 22 | 2% |
| Angiodynamics, Inc. | 19 | 2% |
| Medline Industries, Inc. | 18 | 2% |
| Mckesson Medical-Surgical Inc. | 14 | 1% |
| Exel International | 14 | 1% |
Company = labeler of record on GUDID. 16 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| FPA | Set, administration, intravascular | 709 |
| FPA | Set, Administration, Intravascular | 215 |
| PTI | Non-Coring (Huber) Needle | 96 |
| FRN | Pump, Infusion | 76 |
| FMI | Needle, Hypodermic, Single Lumen | 64 |
| FMI | Needle, hypodermic, single lumen | 56 |
Use these as the dimensions to specify in a tender line.
1,025 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Vascular port administration set", from 16 companies. The largest labeler is Bard Access Systems, Inc. with 59% of records.
FPA (Set, administration, intravascular), FPA (Set, Administration, Intravascular), PTI (Non-Coring (Huber) Needle), FRN (Pump, Infusion)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add vascular port administration set to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.